{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:37:47Z","timestamp":1769560667798,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jiph.2023.10.039","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T16:09:37Z","timestamp":1699027777000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Metronidazole prescribing practices in Australian hospitals: Measuring guideline compliance and appropriateness to support antimicrobial stewardship"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6733-418X","authenticated-orcid":false,"given":"Simone","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Thursky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5407-340X","authenticated-orcid":false,"given":"Alexandros","family":"Chronas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-8895","authenticated-orcid":false,"given":"Courtney","family":"Ierano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jiph.2023.10.039_bib1","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/647939","article-title":"Metronidazole is still the drug of choice for treatment of anaerobic infections","volume":"50","author":"Lofmark","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2023.10.039_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","article-title":"Metronidazole. A therapeutic review and update","volume":"54","author":"Freeman","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jiph.2023.10.039_bib3","series-title":"Therapeutic Guidelines: Antibiotic","author":"Antibiotic Expert Groups","year":"2019"},{"issue":"7","key":"10.1016\/j.jiph.2023.10.039_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/11534490-000000000-00000","article-title":"Anaerobic infections","volume":"70","author":"Nagy","year":"2010","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiac.2015.10.010","article-title":"Spectrum and treatment of anaerobic infections","volume":"22","author":"Brook","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiph.2023.10.039_bib6","series-title":"Antimicrobial stewardship in Australian health care 2018","author":"Australian Commission on Safety and Quality in Health Care","year":"2018"},{"key":"10.1016\/j.jiph.2023.10.039_bib7","series-title":"Priority Antibacterial List for Antimicrobial Resistance Containment: A stewardship resource for human health","author":"Australian Commission on Safety and Quality in Health Care","year":"2020"},{"issue":"9","key":"10.1016\/j.jiph.2023.10.039_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S0031182017002025","article-title":"A review on metronidazole: an old warhorse in antimicrobial chemotherapy","volume":"146","author":"Leitsch","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.jiph.2023.10.039_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.anaerobe.2018.10.004","article-title":"Metronidazole resistance and nim genes in anaerobes: a review","volume":"55","author":"Alauzet","year":"2019","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-018-9147-6","article-title":"Metronidazole-induced encephalopathy: a systematic review","volume":"267","author":"S\u00f8rensen","year":"2020","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.jiph.2023.10.039_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3182334b35","article-title":"Metronidazole-induced central nervous system toxicity: a systematic review","volume":"34","author":"Kuriyama","year":"2011","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.jiph.2023.10.039_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.crad.2019.11.002","article-title":"Acute metronidazole-induced neurotoxicity: an update on MRI findings","volume":"75","author":"Patel","year":"2020","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.jiph.2023.10.039_bib13","doi-asserted-by":"crossref","first-page":"2200910","DOI":"10.1183\/13993003.00910-2022","article-title":"In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes","volume":"61","author":"Chanderraj","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiph.2023.10.039_bib14","series-title":"National Safety and Quality Health Service Standards","author":"Australian Commission on Safety and Quality in Health Care","year":"2017"},{"key":"10.1016\/j.jiph.2023.10.039_bib15","series-title":"Antimicrobial Prescribing Practice in Australian Hospitals: Results of the 2020 Hospital National Antimicrobial Prescribing Survey","author":"Royal Melbourne Hospital and the National Centre for Antimicrobial Stewardship","year":"2023"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac012","article-title":"The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian National Antimicrobial Prescribing Survey","volume":"4","author":"James","year":"2022","journal-title":"JAC-Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.idh.2016.01.002","article-title":"Evaluating antimicrobial therapy: how reliable are remote assessors?","volume":"21","author":"Cotta","year":"2016","journal-title":"Infect, Dis Health"},{"key":"10.1016\/j.jiph.2023.10.039_bib18","series-title":"Intravenous Piperacillin\u2013Tazobactam: Disruption to Supply","author":"NSW Clinical Excellence Commission","year":"2017"},{"key":"10.1016\/j.jiph.2023.10.039_bib19","unstructured":"Therapeutic Goods Administration. Metronidazole - medicine shortage information: Therapeutic Goods Administration; 2022 [updated 2022 Aug 17; cited 2022 Aug 29]. Available from: \u3008https:\/\/apps.tga.gov.au\/shortages\/search\/Details\/metronidazole\u3009."},{"issue":"2","key":"10.1016\/j.jiph.2023.10.039_bib20","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2017","author":"Davey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jiph.2023.10.039_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","article-title":"Antimicrobial stewardship","volume":"86","author":"Doron","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"1151","key":"10.1016\/j.jiph.2023.10.039_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/postgradmedj-2021-139940","article-title":"Improving metronidazole prescription practices in surgical patients: a full cycle audit","volume":"97","author":"Sgro","year":"2021","journal-title":"Post Med J"},{"issue":"Supplement_2","key":"10.1016\/j.jiph.2023.10.039_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac053.003","article-title":"P03 Improving antimicrobial stewardship and sustainability by promoting oral metronidazole in eligible surgical patients at the Royal Alexandra Hospital","volume":"4","author":"Rodger","year":"2022","journal-title":"JAC-Antimicrob Resist"},{"issue":"10","key":"10.1016\/j.jiph.2023.10.039_bib24","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.10.039_bib25","series-title":"Surgical Prophylaxis Prescribing in Australian Hospitals. Results of the 2020 Surgical National Antimicrobial Prescribing Survey","author":"Royal Melbourne Hospital and the National Centre for Antimicrobial Stewardship","year":"2023"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib26","doi-asserted-by":"crossref","first-page":"dlac012","DOI":"10.1093\/jacamr\/dlac012","article-title":"The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian national antimicrobial prescribing survey","volume":"4","author":"James","year":"2022","journal-title":"JAC Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.jiph.2023.10.039_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad100","article-title":"Antibiotic use and quality indicators of antibiotic prescription in Bhutan: a point prevalence survey using the Australian national antimicrobial prescribing survey tool","volume":"5","author":"Chuki","year":"2023","journal-title":"JAC-Antimicrob Resist"},{"issue":"7","key":"10.1016\/j.jiph.2023.10.039_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5694\/mja11.10298","article-title":"New aspirations: the debate on aspiration pneumonia treatment guidelines","volume":"195","author":"Kwong","year":"2011","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.idc.2012.11.016","article-title":"How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy","volume":"27","author":"Bartlett","year":"2013","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.jiph.2023.10.039_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18773\/austprescr.2003.009","article-title":"Aspiration pneumonia and pneumonitis","volume":"26","author":"O'Connor","year":"2003","journal-title":"Aust Prescr"},{"issue":"3","key":"10.1016\/j.jiph.2023.10.039_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40121-016-0122-1","article-title":"A comparison of current guidelines of five international societies on clostridium difficile infection management","volume":"5","author":"Feh\u00e9r","year":"2016","journal-title":"Infect Dis Ther"},{"issue":"5","key":"10.1016\/j.jiph.2023.10.039_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.jiph.2023.10.039_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention ofclostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"J Am Coll Gastroenterol"},{"key":"10.1016\/j.jiph.2023.10.039_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European society of clinical microbiology and infectious diseases: update of the treatment guidance document for clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2023.10.039_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13017-015-0033-6","article-title":"WSES guidelines for management of Clostridium difficile infection in surgical patients","volume":"10","author":"Sartelli","year":"2015","journal-title":"World J Emerg Surg"},{"issue":"4","key":"10.1016\/j.jiph.2023.10.039_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/imj.13027","article-title":"Australasian society of infectious diseases updated guidelines for the management of clostridium difficile infection in adults and children in Australia and New Zealand","volume":"46","author":"Trubiano","year":"2016","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.jiph.2023.10.039_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2023.10.039_bib38","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jiph.2023.10.039_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.10.039_bib40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"Van Prehn","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123003775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123003775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:19:58Z","timestamp":1761751198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034123003775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"alternative-id":["S1876034123003775"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2023.10.039","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metronidazole prescribing practices in Australian hospitals: Measuring guideline compliance and appropriateness to support antimicrobial stewardship","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2023.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}